Bianchi G, Cusi D, Vezzoli G
Institute of Medical Sciences, Postgraduate School of Nephrology, University of Milano, Italy.
Semin Nephrol. 1988 Jun;8(2):110-9.
The differences observed among rat strains in both basal [Na+]i and the several cation transport systems seem to be due to the different genetic background as clearly shown in F2 populations or after bone marrow transplantation in MHS. The same may be true for humans. In spite of all the caution taken in interpreting the data, because of the great possibility of methodological errors, it is likely that the differences observed in many laboratories are due to uneven genetic or ethnic composition of the samples studied, as shown by Dagher and Canessa. One intriguing observation is that most reports of "low Na-K cotransport" values in hypertensive patients are from Mediterranean countries (Italy, France, and Spain), whereas most reports of "high," or "not low Na-K cotransport," or very high values of countertransport came from populations originating from North Europe (Denmark, USA, South African whites). We are not aware of any study on erythrocyte Na-K cotransport performed in Great Britain (the greatest source of American immigrants). Indeed the difference in cotransport values between North and South European hypertensives might be due to different environmental factors, but if this is so, the difference does not depend on the salt consumption or plasma lipids that are similar in our high and low Na-K cotransport hypertensives (Cusi D et al, submitted). The picture seems relatively less confusing for calcium. The most consistent alterations in different models of hypertension is a decreased Ca-pump in SHR, MHS, and DOCA rats, reduced calcium binding in SHR and MHS, and reduced microsomal ATP dependent calcium uptake in SHR and DOCA rats. [Ca++]i, which is increased in established hypertension in man and rats, is normal in young prehypertensive rats and humans, and returns to normal values after pharmacological treatment of hypertension. This pattern of changes suggests that genetic control of these transport systems is weaker, and probably much influenced by different environmental conditions. However, because of the pivotal role of calcium in vascular smooth muscle cell concentration, its intracellular increase may be the common pathway of the different forms of hypertension. What remains unclear is the relation, if any, between calcium and sodium. Blaustein tried to find a link between them, but his hypotheses have yet to be confirmed.
在基础细胞内钠离子浓度以及几种阳离子转运系统方面,不同大鼠品系间观察到的差异似乎归因于不同的遗传背景,这在F2群体中或MHS骨髓移植后得到了明确体现。人类可能也是如此。尽管在解读数据时已极为谨慎,但由于方法学误差的可能性很大,许多实验室观察到的差异很可能是由于所研究样本的遗传或种族构成不均衡,正如达盖尔和卡内萨所指出的那样。一个有趣的现象是,高血压患者中“钠钾协同转运降低”值的大多数报告来自地中海国家(意大利、法国和西班牙),而“高”或“非低钠钾协同转运”或反向转运非常高值的大多数报告则来自北欧(丹麦、美国、南非白人)的人群。我们不清楚在英国(美国移民的最大来源国)是否有关于红细胞钠钾协同转运的研究。事实上,北欧和南欧高血压患者之间协同转运值的差异可能是由于不同的环境因素,但即便如此,这种差异并不取决于我们高钠钾协同转运和低钠钾协同转运高血压患者中相似的盐摄入量或血浆脂质(库西D等人,待发表)。钙的情况似乎相对没那么复杂。在不同高血压模型中最一致的改变是,自发性高血压大鼠(SHR)、遗传性高血压大鼠(MHS)和去氧皮质酮盐高血压大鼠(DOCA大鼠)中钙泵减少,SHR和MHS中钙结合减少,以及SHR和DOCA大鼠微粒体中依赖三磷酸腺苷(ATP)的钙摄取减少。在人类和大鼠的已确诊高血压中升高的细胞内钙离子浓度,在年轻的高血压前期大鼠和人类中是正常的,并且在高血压药物治疗后恢复到正常值。这种变化模式表明,这些转运系统的遗传控制较弱,并且可能在很大程度上受不同环境条件的影响。然而,由于钙在血管平滑肌细胞浓度中起关键作用,其细胞内浓度升高可能是不同形式高血压的共同途径。尚不清楚的是钙和钠之间是否存在关联,如果有的话,是什么关联。布劳斯坦试图找到它们之间的联系,但他的假设尚未得到证实。